These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3958271)

  • 21. Clinical Recognition of Melanoma in Dermatologists and Nondermatologists.
    Martinka MJ; Crawford RI; Humphrey S
    J Cutan Med Surg; 2016 Nov; 20(6):532-535. PubMed ID: 26676952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of melanoma from benign mimics using the relative-color method.
    LeAnder R; Chindam P; Das M; Umbaugh SE
    Skin Res Technol; 2010 Aug; 16(3):297-304. PubMed ID: 20636998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fascin expression in melanocytic lesions of the skin.
    YILDIZ L; KEFELI M; AYDIN O; KANDEMIR B
    Eur J Dermatol; 2009; 19(5):445-50. PubMed ID: 19527987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update and clinical use of imaging technologies for pigmented lesions of the skin.
    O'Donnell AT; Kim CC
    Semin Cutan Med Surg; 2012 Mar; 31(1):38-44. PubMed ID: 22361288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ugly Duckling Sign as a Major Factor of Efficiency in Melanoma Detection.
    Gaudy-Marqueste C; Wazaefi Y; Bruneu Y; Triller R; Thomas L; Pellacani G; Malvehy J; Avril MF; Monestier S; Richard MA; Fertil B; Grob JJ
    JAMA Dermatol; 2017 Apr; 153(4):279-284. PubMed ID: 28196213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solar elastosis and cutaneous melanoma: a site-specific analysis.
    Kvaskoff M; Pandeya N; Green AC; Perry S; Baxter C; Davis MB; Mortimore R; Westacott L; Wood D; Triscott J; Williamson R; Whiteman DC
    Int J Cancer; 2015 Jun; 136(12):2900-11. PubMed ID: 25403328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating clinical/dermatoscopic findings and fluorescence in situ hybridization in diagnosing melanocytic neoplasms with less than definitive histopathologic features.
    Nardone B; Martini M; Busam K; Marghoob A; West DP; Gerami P
    J Am Acad Dermatol; 2012 Jun; 66(6):917-22. PubMed ID: 21962759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melanoma risk factors and atypical moles.
    Williams ML; Sagebiel RW
    West J Med; 1994 Apr; 160(4):343-50. PubMed ID: 8023484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supply-and-demand discrepancy in academic pigmented lesion clinics: a case for a new health care delivery model.
    Vickery EL; Seidler EM; Jones TE; Veledar E; Chen SC
    JAMA Dermatol; 2014 Nov; 150(11):1167-72. PubMed ID: 25028988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The "ugly duckling" sign: agreement between observers.
    Scope A; Dusza SW; Halpern AC; Rabinovitz H; Braun RP; Zalaudek I; Argenziano G; Marghoob AA
    Arch Dermatol; 2008 Jan; 144(1):58-64. PubMed ID: 18209169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanomas detected with the aid of total cutaneous photography.
    Feit NE; Dusza SW; Marghoob AA
    Br J Dermatol; 2004 Apr; 150(4):706-14. PubMed ID: 15099367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Confocal scanning laser microscopy of benign and malignant melanocytic skin lesions in vivo.
    Langley RG; Rajadhyaksha M; Dwyer PJ; Sober AJ; Flotte TJ; Anderson RR
    J Am Acad Dermatol; 2001 Sep; 45(3):365-76. PubMed ID: 11511832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnostic yield in submitting nevi for histologic examination.
    Reeck MC; Chuang TY; Eads TJ; Faust HB; Farmer ER; Hood AF
    J Am Acad Dermatol; 1999 Apr; 40(4):567-71. PubMed ID: 10188675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical (dysplastic) nevi: outcomes of surgical excision and association with melanoma.
    Reddy KK; Farber MJ; Bhawan J; Geronemus RG; Rogers GS
    JAMA Dermatol; 2013 Aug; 149(8):928-34. PubMed ID: 23760581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of acquired nevus-cell nevi in clinical practice].
    Sigg C
    Ther Umsch; 1989 Feb; 46(2):133-7. PubMed ID: 2928982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview.
    Kanzler MH; Mraz-Gernhard S
    J Am Acad Dermatol; 2001 Aug; 45(2):260-76. PubMed ID: 11464189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
    Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
    Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear and cytoplasmic features in the diagnosis of Clark's nevi.
    Valdebran M; Bandino J; Elbendary A; Gad A; Arudra KC; de Feraudy S; Elston DM
    J Cutan Pathol; 2018 Mar; 45(3):204-207. PubMed ID: 29193203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Digital computer analysis of dermatoscopical images of 260 melanocytic skin lesions; perimeter/area ratio for the differentiation between malignant melanomas and melanocytic nevi.
    Fikrle T; Pizinger K
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):48-55. PubMed ID: 17207167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nevus counting as a risk factor for melanoma: comparison of self-count with count by physician.
    Lawson DD; Moore DH; Schneider JS; Sagebiel RW
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 1):438-44. PubMed ID: 8077469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.